DUBLIN — April 2, 2020 — Horizon Therapeutics plc (Nasdaq: HZNP) announced today that it has acquired Curzion Pharmaceuticals, Inc., a privately held development-stage biopharma company, and its development-stage oral...
Art Pappas is participating in a health reform panel discussion for the Capitolbeat Annual Conference in Indianapolis, IN
News | 08. 21. 2009
© 2020 Pappas Capital, LLC. ALL RIGHTS RESERVED.